Sarepta Therapeutics suffered another major setback on Friday as Europe's drug regulator decided not to recommend the ...

Sarepta and Roche face a regulatory setback as the EMA's CHMP issues a negative opinion on Elevidys for Duchenne muscular ...

Sarepta Therapeutics' brutal week continued Friday after European officials rejected the company's controversial gene therapy ...

Sarepta Therapeutics Inc. shares plunged after European regulators rejected its gene therapy Elevidys, intensifying scrutiny on the drugmaker after it was pressured to halt shipments of its treatment ...

The European Medicines Agency determined testing failed to prove Elevidys’ benefit and issued a negative opinion that could ...

Detailed price information for Zimmer Biomet Holdings (ZBH-N) from The Globe and Mail including charting and trades.

You don't like to see analyst opinions sour heading into a critical financial update. Thankfully, that was the only downgrade this week.

I wonder whether the framing of the liturgy itself in instrumentalizing terms may unintentionally reinscribe problematic views of the relationship between the human and more-than-human world.

The newly published Data Quadrant from Info-Tech Research Group highlights the leading PAM solutions that help organizations secure sensitive accounts and manage privileged access effectively. The ...

EU ministers gave the final green light on Tuesday for Bulgaria to adopt the euro on January 1, 2026, making it the single currency area's 21st member.